Macular Dystrophy

Common Name(s)

Macular Dystrophy

Macular dystrophy is a genetic eye disorder that causes vision loss. It causes damage to the area of the eye called the macula, which is responsible for central vision. When the macula is damaged, people have trouble seeing straight ahead. Vision becomes blurry and distorted. However, side (peripheral) vision is not affected. Vision slowly worsens over time. Unfortunately, there is no treatment available for macular dystrophy at this time. However, promising new research is currently being conducted.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Macular Dystrophy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Macular Dystrophy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Macular Dystrophy" returned 154 free, full-text research articles on human participants. First 3 results:

Quantitative fundus autofluorescence and optical coherence tomography in best vitelliform macular dystrophy.
 

Author(s): Tobias Duncker, Jonathan P Greenberg, Rithambara Ramachandran, Donald C Hood, R Theodore Smith, Tatsuo Hirose, Russell L Woods, Stephen H Tsang, François C Delori, Janet R Sparrow

Journal:

 

Quantitative fundus autofluorescence (qAF), spectral domain optical coherence tomography (SD-OCT) segmentation, and multimodal imaging were performed to elucidate the pathogenesis of Best vitelliform macular dystrophy (BVMD) and to identify abnormalities in lesion versus nonlesion fundus areas.

Last Updated: 14 Mar 2014

Go To URL
Novel GUCA1A mutations suggesting possible mechanisms of pathogenesis in cone, cone-rod, and macular dystrophy patients.
 

Author(s): Kunka Kamenarova, Marta Corton, Blanca García-Sandoval, Patricia Fernández-San Jose, Valentin Panchev, Almudena Avila-Fernández, Maria Isabel López-Molina, Christina Chakarova, Carmen Ayuso, Shomi S Bhattacharya

Journal: Biomed Res Int. 2013 ;2013():517570.

 

Here, we report two novel GUCA1A (the gene for guanylate cyclase activating protein 1) mutations identified in unrelated Spanish families affected by autosomal dominant retinal degeneration (adRD) with cone and rod involvement. All patients from a three-generation adRD pedigree underwent ...

Last Updated: 11 Sep 2013

Go To URL
Outer retinal structure in best vitelliform macular dystrophy.
 

Author(s): David B Kay, Megan E Land, Robert F Cooper, Adam M Dubis, Pooja Godara, Alfredo Dubra, Joseph Carroll, Kimberly E Stepien

Journal: JAMA Ophthalmol. 2013 Sep;131(9):1207-15.

 

Demonstrating the utility of adaptive optics scanning light ophthalmoscopy (AOSLO) to assess outer retinal structure in Best vitelliform macular dystrophy (BVMD).

Last Updated: 13 Sep 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Macular Dystrophy" returned 1 free, full-text review articles on human participants. First 3 results:

Macular corneal dystrophy. Studies of sulfated glycosaminoglycans in corneal explant and confluent stromal cell cultures.
 

Author(s): G K Klintworth, C F Smith

Journal: Am. J. Pathol.. 1977 Oct;89(1):167-82.

 

The inherited disorder macular corneal dystrophy (MCD), a localized corneal mucopolysaccharidosis, is currently thought to result from an inability to catabolize corneal keratan sulfate (keratan sulfate 1). As studies on isolated cells have provided insight into metabolic abnormalities ...

Last Updated: 30 Nov 1977

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
 

Status: Recruiting

Condition Summary: Stargardt's Macular Dystrophy; Fundus Flavimaculatus; Juvenile Macular Dystrophy

 

Last Updated: 9 Apr 2014

Go to URL
Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy
 

Status: Recruiting

Condition Summary: Stargardt's Macular Dystrophy

 

Last Updated: 10 Apr 2014

Go to URL
Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD)
 

Status: Recruiting

Condition Summary: Stargardt's Macular Dystrophy

 

Last Updated: 22 Oct 2012

Go to URL